Philip Borden

Philip Borden

Chief Executive Officer at Labshares Newton LLC

Finance
Consumer Services
Technology Services

Profile

Philip A.
Borden
is currently the Chief Executive Officer at LabShares Newton LLC and a Director at BALX Holdings LLC, Galen Evolve SPV LLC, and MitoAction.
He was previously the Chairman at BioAgilytix Labs LLC, a Director at Pilgrim Quality Solutions, Inc., a Managing Director at Galen Management LLC, a Principal at Frazier Management LLC and Oxford Bioscience Partners, and a General Partner at Riverside Partners LLC.
Borden received his undergraduate degree from Duke University and his MBA from Harvard Business School.

Philip Borden active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -
MitoAction President -
Chief Executive Officer 2023-07-31
All active positions of Philip Borden

Former positions of Philip Borden

CompaniesPositionEnd
Private Equity Investor 2020-12-31
Private Equity Analyst 2004-12-30
Chairman -
Chairman -
Corporate Officer/Principal 2004-12-30
See the detail of Philip Borden's experience

Training of Philip Borden

Duke University Undergraduate Degree
Harvard Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Philip Borden's experience

Connections

17

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies10

Finance

Finance

Technology Services

Finance

Finance

Commercial Services

Health Technology

MitoAction

Finance

Finance

See company connections